ES2087434T3 - Analogos de hormona del crecimiento humana y su empleo. - Google Patents

Analogos de hormona del crecimiento humana y su empleo.

Info

Publication number
ES2087434T3
ES2087434T3 ES92202956T ES92202956T ES2087434T3 ES 2087434 T3 ES2087434 T3 ES 2087434T3 ES 92202956 T ES92202956 T ES 92202956T ES 92202956 T ES92202956 T ES 92202956T ES 2087434 T3 ES2087434 T3 ES 2087434T3
Authority
ES
Spain
Prior art keywords
mutants
human growth
hgh
hormone
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92202956T
Other languages
English (en)
Inventor
Guido Grandi
Giuliano Galli
Y Ros Immaculada Margarit
Susanna Campagnoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eni Tecnologie SpA
Original Assignee
Eniricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche SpA filed Critical Eniricerche SpA
Application granted granted Critical
Publication of ES2087434T3 publication Critical patent/ES2087434T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A MUTANTES DE LA HORMONA DE CRECIMIENTO HUMANA (HGH) EN QUE EL RESIDUO AMINOACIDO DE ARGININA (ARG) SE HA SUSTITUIDO EN LA POSICION 134 DE LA SECUENCIA AMINOACIDA DE LA HGH NATURAL POR UN RESIDUO AMINOACIDO ELEGIDO DEL GRUPO QUE CONSISTE EN L L ESTOS MUTANTES HAN DEMOSTRADO UNA ESTABILIDAD MEJOR HACIA LA DEGRADACION ENZIMATICA QUE LA HGH NATURAL Y UNA ACTIVIDAD BIOLOGICA INALTERADA. LOS MUTANTES SE PUEDEN UTILIZAR EN EL AMBITO TERAPEUTICO PARA EL TRATAMIENTO DE DISFUNCIONES DE LA HIPOFISIS Y EN LA CURA DE ESTADOS PATOLOGICOS TALES COMO QUEMADURAS, DISTROFIAS, PSEUDOARTROSIS Y FRACTURAS DE HUESOS.
ES92202956T 1991-09-27 1992-09-25 Analogos de hormona del crecimiento humana y su empleo. Expired - Lifetime ES2087434T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912582A IT1251895B (it) 1991-09-27 1991-09-27 Mutanti dell'ormone della crescita umano e loro impiego

Publications (1)

Publication Number Publication Date
ES2087434T3 true ES2087434T3 (es) 1996-07-16

Family

ID=11360779

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92202956T Expired - Lifetime ES2087434T3 (es) 1991-09-27 1992-09-25 Analogos de hormona del crecimiento humana y su empleo.

Country Status (7)

Country Link
EP (1) EP0534568B1 (es)
JP (1) JPH05310794A (es)
AT (1) ATE138098T1 (es)
DE (1) DE69210733T2 (es)
DK (1) DK0534568T3 (es)
ES (1) ES2087434T3 (es)
IT (1) IT1251895B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000837D0 (sv) 2000-03-13 2000-03-13 Pharmacia & Upjohn Ab New use
JP2003079379A (ja) * 2001-09-13 2003-03-18 Itoham Foods Inc 成長ホルモンの高発現用ｄｎａおよびその使用
GB2389115B (en) * 2001-12-14 2005-03-16 Asterion Ltd Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone
KR20110039348A (ko) 2008-08-06 2011-04-15 노보 노르디스크 헬스 케어 악티엔게젤샤프트 연장된 생체내 효능을 가지는 콘쥬게이트된 단백질
JP5816097B2 (ja) 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
JP6086528B2 (ja) 2009-08-06 2017-03-01 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 長期のインビボ有効性を有する成長ホルモン
CN118767117A (zh) 2010-01-22 2024-10-15 诺沃—诺迪斯克保健股份有限公司 体内功效延长的生长激素
JP5980689B2 (ja) * 2010-01-22 2016-08-31 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
EP2595661A1 (en) 2010-07-22 2013-05-29 Novo Nordisk Health Care AG Growth hormone conjugates
US11045523B2 (en) 2013-04-05 2021-06-29 Novo Nordisk Healthcare Ag Formulation of growth hormone albumin-binder conjugate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223577B (it) * 1987-12-22 1990-09-19 Eniricerche Spa Procedimento migliorato per la preparazione dell'ormone della crescita umano naturale in forma pura

Also Published As

Publication number Publication date
ITMI912582A0 (it) 1991-09-27
ITMI912582A1 (it) 1993-03-27
DE69210733D1 (de) 1996-06-20
IT1251895B (it) 1995-05-26
EP0534568B1 (en) 1996-05-15
EP0534568A3 (es) 1994-03-16
EP0534568A2 (en) 1993-03-31
ATE138098T1 (de) 1996-06-15
DK0534568T3 (da) 1996-07-15
JPH05310794A (ja) 1993-11-22
DE69210733T2 (de) 1996-10-02

Similar Documents

Publication Publication Date Title
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
PA8435301A1 (es) Derivados del acido arilsulfonilamino hidroxamico.
ES2087434T3 (es) Analogos de hormona del crecimiento humana y su empleo.
BRPI0109494B8 (pt) muteína de fator viii, sequência de dna, vetor, processo para produção da muteína de fator viii, composição farmacêutica e uso da muteína do fator viii
MX9301700A (es) Muteinas del factor de necrosis tumoral humano, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
BR9608019A (pt) Uma nova proteína e um processo para a preparação da mesma'
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
BR0314619A (pt) Análogos de ghrh
ES545760A0 (es) Procedimiento para preparar peptidos liberadores de la hormona del crecimiento.
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
Sundell et al. 1, 25 (OH) 2 vitamin D3 increases ionized plasma calcium concentrations in the immature Atlantic cod Gadus morhua
AU2018362018A1 (en) Peptide conjugate CGRP receptor antagonists and methods of preparation and uses thereof
BR9811755A (pt) Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica
ATE537834T1 (de) 2-methylen-19-nor-vitamin d2-verbindungen
PE20040961A1 (es) Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel
EP0264750A2 (de) Wachstumshormon-Releasingfaktor-Analoga
BR0008776A (pt) Análogos de prostaglandinas fp-seletivosinsaturados c16
Lidor et al. Healing of rachitic lesions in chicks by 24R, 25‐dihydroxycholecalciferol administered locally into bone
RAISZ et al. Inhibition of bone resorption by colchicine in organ culture
EP0110294B1 (de) Mittel zur Behandlung der Osteoporose
AR003974A1 (es) Una nueva proteina mp52 arg humana, un proceso para la produccion y aislacion de la misma y composiciones farmaceuticas que la contienen
CO5640064A2 (es) Citomodilacion de peptidos para tratar cistitis intersticial
AR010924A1 (es) Azapeptidos ciclicos, sus enantiomeros y diastereomeros, un procedimiento para su preparacion, su empleo para preparar un medicamento, las preparacionesfarmaceuticas que los contienen y un procedimiento para obtener estas preparaciones farmaceuticas.
DE3676640D1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0534568

Country of ref document: ES